Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Adaptimmune therapeutics plc symbols : NVS save search
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
Published: 2024-02-27 (Crawled : 15:30) - biospace.com/
TSVT | $4.65 -8.1% -8.82% 710K
|
|
| O: 0.0%
H: 8.64%
C: 8.36%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.15%
H: 0.31%
C: 0.06%
BLBD | $33.6 -1.81% -1.85% 510K
|
Producer Manufacturing
|
| O: 1.02%
H: 1.29%
C: 1.17%
ALVR | $0.74 -2.23% -2.28% 530K
|
Health Technology
|
| O: -1.42%
H: 7.9%
C: 3.52%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 3.05%
H: 5.92%
C: 1.18%
pdufa commercial
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published: 2023-12-12 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.56%
H: 0.51%
C: 0.51%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -5.13%
H: 5.41%
C: 3.46%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.45%
H: 0.75%
C: 0.46%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.18%
H: 0.43%
C: 0.25%
GBIO | $2.775 -6.88% -7.39% 200K
|
Health Technology
|
| O: 5.62%
H: 3.72%
C: -4.26%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.59%
H: 1.35%
C: 0.6%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 1.83%
H: 0.04%
C: -1.13%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -0.46%
H: 5.56%
C: -1.12%
ABEO | $7.55 -4.79% -5.03% 250K
|
Health Technology
|
| O: 0.65%
H: 2.59%
C: 0.86%
america therapy growth market
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
|
| O: 3.87%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -3.37%
H: 4.51%
C: 4.51%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.25%
H: 0.68%
C: 0.48%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
GBIO | $2.775 -6.88% -7.39% 200K
|
Health Technology
|
| O: 0.0%
H: 38.05%
C: 23.01%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.06%
H: 0.35%
C: 0.29%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: 0.92%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -5.76%
H: 16.36%
C: 15.07%
ABEO | $7.55 -4.79% -5.03% 250K
|
Health Technology
|
| O: -2.43%
H: 0.0%
C: 0.0%
research growing therapy market
Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market growth- Technavio
Published: 2023-11-03 (Crawled : 23:00) - prnewswire.com
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ABEO | $7.55 -4.79% -5.03% 250K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
| Email alert
Add to watchlist
GBIO | $2.775 -6.88% -7.39% 200K
|
Health Technology
| Email alert
Add to watchlist
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
| Email alert
Add to watchlist
AAPL | News S | $167.03 -0.58% -0.58% 42M
|
Electronic Technology
| Email alert
Add to watchlist
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
| Email alert
Add to watchlist
america therapy market
Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -0.68%
H: 3.23%
C: 1.55%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -0.76%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.62%
H: 4.57%
C: 2.04%
GBIO | $2.775 -6.88% -7.39% 200K
|
Health Technology
|
| O: 0.0%
H: 11.57%
C: 6.4%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.99%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: -0.86%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -0.75%
H: 7.14%
C: 6.12%
ABEO | $7.55 -4.79% -5.03% 250K
|
Health Technology
|
| O: 0.0%
H: 4.4%
C: 3.29%
drug set therapy growth market
Global Pancreatic Cancer Competitive Landscape Report 2023: Comprehensive Insights about 250+ Companies and 300+ Drugs
Published: 2023-05-08 (Crawled : 15:00) - prnewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.11%
H: 0.72%
C: 0.3%
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 6.91%
H: 1.49%
C: -2.49%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.03%
H: 0.17%
C: -1.19%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 4.23%
H: 0.0%
C: -4.4%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 1.43%
H: 2.11%
C: -1.41%
companies report cancer pancreatic global
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027; The increase in special drug designations to drive growth- Technavio
Published: 2023-03-16 (Crawled : 02:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.16%
H: 0.73%
C: 0.73%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 0.44%
H: 0.29%
C: 0.29%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.18%
H: 0.77%
C: 0.64%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: -6.05%
GBIO | $2.775 -6.88% -7.39% 200K
|
Health Technology
|
| O: -0.55%
H: 6.69%
C: 1.95%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -1.11%
H: 2.97%
C: 2.23%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.49%
H: 0.39%
C: 0.36%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -2.65%
H: 14.55%
C: 9.09%
ABEO | $7.55 -4.79% -5.03% 250K
|
Health Technology
|
| O: -2.29%
H: 3.52%
C: -0.78%
drug therapy market
Global Gene Therapy Market to Grow by $4.61 Billion During 2023-2027
Published: 2023-03-14 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 1.01%
H: 0.43%
C: 0.29%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.28%
H: 0.38%
C: 0.31%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.01%
H: 7.6%
C: 7.6%
GBIO | $2.775 -6.88% -7.39% 200K
|
Health Technology
|
| O: 3.79%
H: 2.61%
C: -1.57%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 1.4%
H: 1.39%
C: 0.07%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -1.23%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 0.9%
H: 4.46%
C: 2.68%
ABEO | $7.55 -4.79% -5.03% 250K
|
Health Technology
|
| O: 2.79%
H: 8.53%
C: 0.78%
global therapy market
Cancer Gene Therapy Market To Reach a Valuation of USD 4047.8 Million by 2028 - Comprehensive Research Report by BrandEssence Market Research
Published: 2022-12-02 (Crawled : 12:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: -3.13%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -0.61%
H: 0.08%
C: -0.29%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.08%
H: 1.44%
C: 1.28%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.29%
H: 1.55%
C: 1.2%
CRNX | $43.005 -2.28% -2.34% 540K
|
Health Technology
|
| O: -0.57%
H: 5.9%
C: 5.44%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.23%
H: 0.79%
C: 0.43%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -0.99%
H: 6.5%
C: 3.0%
research report therapy cancer market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO 2 d | $10.22 -7.68% -8.32% 400K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.6917 -3.25% -3.35% 830K
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published: 2022-06-27 (Crawled : 15:20) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
CRNX | $43.005 -2.28% -2.34% 540K
|
Health Technology
|
| O: 0.66%
H: 1.22%
C: -5.83%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.08%
H: 0.45%
C: -0.13%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 1.85%
H: 6.67%
C: 3.03%
treatment therapy cancer market
Worldwide Gene Therapy Industry to 2027 - Players Include Amgen, Biogen and Novartis Among Others
Published: 2022-03-04 (Crawled : 21:00) - prnewswire.com
QURE | $4.71 0.86% 0.85% 440K
|
Health Technology
| Email alert
Add to watchlist
ABEO | $7.55 -4.79% -5.03% 250K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
| Email alert
Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
| Email alert
Add to watchlist
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
| Email alert
Add to watchlist
novartis gene therapy therapy
Sarcoma Therapeutics Market 2022-2026 | Patient Assistance Programs to Boost Growth | Technavio
Published: 2022-02-28 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.4%
H: 7.54%
C: 7.54%
CYTR | $0.092
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -3.12%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
KPTI | $1.265 -8.33% -9.09% 1.3M
|
Health Technology
|
| O: 0.1%
H: 0.1%
C: -1.62%
AGEN | News | $4.97 -7.96% -8.65% 1.7M
|
Health Technology
|
| O: -1.31%
H: 0.0%
C: 0.0%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -1.86%
H: 4.92%
C: -1.52%
program therapeutics growth
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
Published: 2022-01-26 (Crawled : 13:30) - biospace.com/
TSVT | $4.65 -8.1% -8.82% 710K
|
|
| O: 1.06%
H: 2.71%
C: -10.48%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.66%
H: 0.26%
C: -1.01%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 1.29%
H: 5.03%
C: -1.78%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 1.75%
H: 3.78%
C: -3.09%
commercialization
Insights on the Kidney Cancer Diagnostics and Therapeutics Global Market to 2026 - Key Motivators, Restraints and Opportunities
Published: 2021-08-05 (Crawled : 16:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.42%
H: 0.31%
C: 0.13%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.69%
H: 0.37%
C: 0.34%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
|
| O: 0.0%
H: 2.03%
C: 1.25%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 1.48%
H: 0.46%
C: 0.43%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 0.58%
H: 4.05%
C: 2.02%
cancer diagnostics kidney diagnostic
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.